NGLFINE vs SUPRIYA: Stock Comparison

NGL FINE CHEM vs SUPRIYA LIFESCIENCEUpdated 4 Sept 26, 4:08 PM ISTNSE & company filings

SUPRIYA LIFESCIENCE is the larger company by market capitalisation. NGL FINE CHEM shows faster revenue growth, while SUPRIYA LIFESCIENCE shows a lower P/E, a higher ROE and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

NGLFINE leads 5; SUPRIYA leads 8 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

NGLFINESUPRIYA

Valuation lens

What price are you paying?

Market CapContext only
₹1,804 Cr
₹6,801 Cr
P/E RatioSUPRIYA has the lower reading
30.41x
0x
P/B RatioSUPRIYA has the lower reading
5.28x
0x
EPSNGLFINE has the higher reading
₹29.78
₹2.99
Book ValueContext only
₹532.9
₹148.82
Dividend YieldSUPRIYA has the higher reading
0.07%
0.12%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
SUPRIYA is the larger company
₹6,801 Cr vs ₹1,804 Cr
P/E Ratio
SUPRIYA has a lower P/E
0x vs 30.41x
P/B Ratio
SUPRIYA has a lower P/B
0x vs 5.28x
EPS
NGLFINE has higher earnings per share
₹29.78 vs ₹2.99
Dividend Yield
SUPRIYA has a higher dividend yield
0.12% vs 0.07%
Revenue Growth (TTM YoY)
NGLFINE has faster revenue growth
57.2% vs 50.2%
EPS Growth (TTM YoY)
NGLFINE has faster EPS growth
1,539.8% vs 46.7%
Qtr Sales Growth
NGLFINE has stronger quarterly sales growth
1.79% vs -31.38%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricNGLFINESUPRIYA
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricNGLFINESUPRIYA
Live Price₹2,907.5₹852.85
Day Change-1.13%1.2%
Volume7,1073.24 L
52-Week High₹3,602₹1,085
52-Week Low₹1,271₹545.5
Distance from 52W High-19.28%-21.4%

Valuation

MetricNGLFINESUPRIYA
Market Cap₹1,804 Cr₹6,801 Cr
P/E Ratio30.41x0x
P/B Ratio5.28x0x
EPS₹29.78₹2.99
Book Value₹532.9₹148.82
Dividend Yield0.07%0.12%

Growth

MetricNGLFINESUPRIYA
Revenue Growth (TTM YoY)57.2%50.2%
EPS Growth (TTM YoY)1,539.8%46.7%
Qtr Sales Growth1.79%-31.38%
Qtr Profit Growth11.83%-67.61%

Profitability & Leverage

MetricNGLFINESUPRIYA
ROE13.01%17.46%
ROCE10.54%18.15%
Net Margin9.59%25.26%
Operating Margin12.08%33.42%
Debt to Equity0.34x0x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricNGLFINESUPRIYA
Promoter Holding72.49% 0.25 pp68.3%
FII Holding0.05% 0.02 pp6.19% 1.03 pp
DII Holding0.02% 0.02 pp5.3% 0.4 pp
Public Holding27.43% 0.19 pp20.21% 0.63 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: NGL FINE CHEM and SUPRIYA LIFESCIENCE.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.